Episode
Beyond the Drip: Infusion Strategy and the Road Ahead with Vic Simianu
- Podcast
- Beyond the Drip Podcast
- Published
- Dec 16, 2025
- Duration seconds
- 3633
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/beyond-the-drip-podcast-6943564/episodes/beyond-the-drip-infusion-strategy-and-the-road-ahead-with-vic-simianu/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/beyond-the-drip-podcast-6943564/beyond-the-drip-infusion-strategy-and-the-road-ahead-with-vic-simianu.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Welcome to Beyond the Drip, where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired. As the year comes to a close, Beyond the Drip delivers a forward-looking conversation on the evolving infusion and specialty pharmacy landscape. In the final episode of the year, our co-hosts sit down with Vic Simianu, CEO and Founder of Sphinx Strategies, to discuss his path into infusion, the mounting pressures on independent pharmacies and what the next three to five years will require from industry leaders. With a background in biotech, finance and early-stage startups, Vic entered specialty pharmacy just as it was emerging as a $60 billion industry, which is now a trillion-dollar market. That experience shaped his decision to launch Sphinx Strategies, recognizing that independent pharmacies needed a way to stay competitive without billion-dollar budgets. Today, Sphinx helps pharmacies strengthen operations, data strategy and long-term growth in an increasingly complex market. Key Takeaways The infusion and specialty pharmacy market has rapidly evolved, increasing pressure on independent providers to adapt and differentiate. Clear value propositions and niche focus are essential as pharmacies face closures and tighter margins. Integrated operations, clinical expertise and data strategy are critical for long-term success and must be driven by leadership. Strong data and disease-state expertise improve access to manufacturers, especially as new cell and gene therapies come to market. P…